[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Primary Progressive Multiple Sclerosis Treatment Market Status and Outlook 2018-2025

August 2018 | 145 pages | ID: G48A356F607EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies
  • F. Hoffmann-La Roche Ltd.
  • Genzyme Corporation
  • Glialogix, Inc.
  • Kyorin Pharmaceutical Co., Ltd.
  • MedDay SA
  • Santhera Pharmaceuticals Holding AG
  • Teva Pharmaceutical Industries Ltd.
Market by Type
  • ApE
  • Biotin
  • GZ-402668
  • Ibudilast
  • Idebenone
  • Laquinimod Sodium
  • Others
Market by Application
  • Hospital
  • Clinic
  • Others
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Primary Progressive Multiple Sclerosis Treatment Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 ApE
  3.1.2 Biotin
  3.1.3 GZ-402668
  3.1.4 Ibudilast
  3.1.5 Idebenone
  3.1.6 Laquinimod Sodium
  3.1.7 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 ApE Production by Region
    6.1.1.2 Biotin Production by Region
    6.1.1.3 GZ-402668 Production by Region
    6.1.1.4 Ibudilast Production by Region
    6.1.1.5 Idebenone Production by Region
    6.1.1.6 Laquinimod Sodium Production by Region
    6.1.1.7 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 ApE Demand by Region
    6.2.1.2 Biotin Demand by Region
    6.2.1.3 GZ-402668 Demand by Region
    6.2.1.4 Ibudilast Demand by Region
    6.2.1.5 Idebenone Demand by Region
    6.2.1.6 Laquinimod Sodium Demand by Region
    6.2.1.7 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 F. Hoffmann-La Roche Ltd.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Genzyme Corporation
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Glialogix, Inc.
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Kyorin Pharmaceutical Co., Ltd.
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 MedDay SA
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Santhera Pharmaceuticals Holding AG
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Teva Pharmaceutical Industries Ltd.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Primary Progressive Multiple Sclerosis Treatment Industry Dynamics & Regulations List
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue, Cost and Margin, 2015-2018E
Table Global Primary Progressive Multiple Sclerosis Treatment Market Status by Type 2015-2018E, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Status by Application 2015-2018E, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Status by Application 2015-2018E, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Region 2015-2018E, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2018, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Market by Region 2015-2018E, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Market Share by Region in 2018, in Volume
Table ApE Production Value by Region 2015-2018E, in USD Million
Table ApE Production Volume by Region 2015-2018E, in Volume
Table Biotin Production Value by Region 2015-2018E, in USD Million
Table Biotin Production Volume by Region 2015-2018E, in Volume
Table GZ-402668 Production Value by Region 2015-2018E, in USD Million
Table GZ-402668 Production Volume by Region 2015-2018E, in Volume
Table Ibudilast Production Value by Region 2015-2018E, in USD Million
Table Ibudilast Production Volume by Region 2015-2018E, in Volume
Table Idebenone Production Value by Region 2015-2018E, in USD Million
Table Idebenone Production Volume by Region 2015-2018E, in Volume
Table Laquinimod Sodium Production Value by Region 2015-2018E, in USD Million
Table Laquinimod Sodium Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table ApE Market Size by Region 2015-2018E, in USD Million
Table ApE Market Size by Region 2015-2018E, in Volume
Table Biotin Market Size by Region 2015-2018E, in USD Million
Table Biotin Market Size by Region 2015-2018E, in Volume
Table GZ-402668 Market Size by Region 2015-2018E, in USD Million
Table GZ-402668 Market Size by Region 2015-2018E, in Volume
Table Ibudilast Market Size by Region 2015-2018E, in USD Million
Table Ibudilast Market Size by Region 2015-2018E, in Volume
Table Idebenone Market Size by Region 2015-2018E, in USD Million
Table Idebenone Market Size by Region 2015-2018E, in Volume
Table Laquinimod Sodium Market Size by Region 2015-2018E, in USD Million
Table Laquinimod Sodium Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalPrimary Progressive Multiple Sclerosis Treatment Forecast by Type 2019F-2025F, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Forecast by Type 2019F-2025F, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast by Region 2019F-2025F, in USD Million
Table Primary Progressive Multiple Sclerosis Treatment Market Forecast by Region 2019F-2025F, in Volume
Table F. Hoffmann-La Roche Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Genzyme Corporation Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Genzyme Corporation
Table Glialogix, Inc. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Glialogix, Inc.
Table Kyorin Pharmaceutical Co., Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Kyorin Pharmaceutical Co., Ltd.
Table MedDay SA Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of MedDay SA
Table Santhera Pharmaceuticals Holding AG Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Santhera Pharmaceuticals Holding AG
Table Teva Pharmaceutical Industries Ltd. Information
Table Primary Progressive Multiple Sclerosis Treatment Sales, Cost, Margin of Teva Pharmaceutical Industries Ltd.
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue by Company 2015-2017, in USD Million
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume by Company 2015-2017, in Volume
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Primary Progressive Multiple Sclerosis Treatment Picture
Figure Primary Progressive Multiple Sclerosis Treatment Industry Chain Diagram
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue 2015-2018E, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume 2015-2018E, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Market Status by Type 2015-2018E, in Volume
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure North America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Europe Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure South America Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Middle East Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in USD Million
Figure Africa Primary Progressive Multiple Sclerosis Treatment Market Size and Growth 2015-2018E, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Price Forecast 2019F-2025F
Figure Global Primary Progressive Multiple Sclerosis Treatment Gross Margin Forecast 2019F-2025F
Figure Global Primary Progressive Multiple Sclerosis Treatment Sales Revenue by Company in 2018, in USD Million
Figure Global Primary Progressive Multiple Sclerosis Treatment Price by Company in 2018
Figure Global Primary Progressive Multiple Sclerosis Treatment Gross Margin by Company in 2018


More Publications